Improving Mesothelioma Survival Rate
Mesothelioma survival rates are steadily improving due to new treatments being developed. Survival rate statistics provide more information to patients about their prognosis.
Estimating Mesothelioma Survival Time
Underreported Factors Affecting Survival Rates
Current Survival Results
Survival rates don’t always reflect current data. Doctors examine the results of people treated in the past in order to provide patients with survival rates. These survival rates only offer a glimpse into the past, not the future.
New Treatment Options
Survival rates cannot account for new treatment options. In many cases these treatments were not available at the time the data was collected. Mesothelioma treatment options have been developing quickly through clinical trials in the past decade. Get connected to clinical trials for innovative treatments.
Survival rates can be misleading because they include patients who didn’t receive treatment or were treated by general oncologists rather than mesothelioma specialists.
Patients and families should remember that all statistics (including survival rates) have a degree of error. While mesothelioma survival rates tend to be low, overall survival rates are constantly improving due to innovative treatment options.
However, following the second year after diagnosis, survival rates for pleural patients drop considerably (11 percent), while survival rates for peritoneal patients only experienced a small decrease (35 percent).
This suggests it is equally hard to detect pleural and peritoneal mesothelioma early enough to effectively treat the disease. These numbers also show treatment for a peritoneal patient is more effective than treatment for a pleural patient.
Due to the rarity of pericardial mesothelioma, there are no conclusive studies to show survival rates for these patients. It is only known that the majority of patients (90 percent) with pericardial mesothelioma were diagnosed after death.
Mesothelioma is more often diagnosed in the later stages because of the lack of specific symptoms of mesothelioma. Survival rates at this stage are lower because the cancer is more advanced and more difficult to treat. However, there are numerous treatment options for patients at any stage. New, noninvasive treatments, like chemotherapy and radiation, are frequently being developed and improved in ongoing clinical trials.
Cell Type & Histology
There is a wide range of studies that show the survival rates based on the cell types of patients. Dr. David Sugarbaker completed a study in 1996 involving 120 mesothelioma patients, which illuminated how important cell type is to survival rates in patients undergoing multimodal therapy. It is important to keep in mind multimodal therapy is the most successful type of treatment for mesothelioma and other studies have varying survival rates. However, patients with an epithelioid cell type tend to do markedly better than other cell types.
Survival Rate by Cell Type After Multimodal Therapy
Survival rate statistics for biphasic cell types aren’t consistent because the ratio of epithelioid cells to sarcomatoid cells varies with each patient. However, patients with biphasic mesothelioma who have a higher percentage of epithelioid cells usually live longer. This complies with the survival rates based on epithelioid and sarcomatoid mesothelioma.
Each cell type is unique, which is why patients should find a mesothelioma specialist to treat them. Mesothelioma specialists can offer specific expertise to their patients. Get connected to a specialist using our free Doctor Match program.